Compare TECH & CRDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TECH | CRDO |
|---|---|---|
| Founded | 1976 | 2008 |
| Country | United States | Cayman Islands |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.1B | 50.7B |
| IPO Year | 1995 | 2022 |
| Metric | TECH | CRDO |
|---|---|---|
| Price | $71.36 | $239.98 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 11 | 14 |
| Target Price | $71.82 | ★ $179.62 |
| AVG Volume (30 Days) | ★ 8.0M | 7.6M |
| Earning Date | 05-06-2026 | 06-01-2026 |
| Dividend Yield | ★ 0.62% | N/A |
| EPS Growth | N/A | ★ 765.52 |
| EPS | 0.81 | ★ 2.51 |
| Revenue | $1,219,635,000.00 | ★ $1,335,116,000.00 |
| Revenue This Year | $2.49 | $210.92 |
| Revenue Next Year | $6.40 | $57.22 |
| P/E Ratio | ★ $88.01 | $102.67 |
| Revenue Growth | 5.23 | ★ 205.68 |
| 52 Week Low | $43.20 | $86.49 |
| 52 Week High | $72.16 | $308.67 |
| Indicator | TECH | CRDO |
|---|---|---|
| Relative Strength Index (RSI) | 76.96 | 47.95 |
| Support Level | $57.46 | $212.83 |
| Resistance Level | N/A | $280.50 |
| Average True Range (ATR) | 0.76 | 24.71 |
| MACD | 0.15 | -3.99 |
| Stochastic Oscillator | 99.24 | 20.24 |
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
Credo Technology Group Holding Ltd provides connectivity solutions for AI-driven applications, cloud computing, and hyperscale networks. Its high-speed copper and optical interconnect products support data infrastructure demands. The Company's product portfolio includes ZeroFlap (ZF) Active Electrical Cables (AECs), ZF optical transceivers, OmniConnect memory solutions, and retimers and DSPs for optical and copper Ethernet and PCIe, leveraging the PILOT diagnostic and analytics software platform. Its products are based on Serializer/Deserializer (SerDes) and Digital Signal Processor (DSP) technologies and include integrated circuits (ICs), Active Electrical Cables (AECs), SerDes Chiplets, and SerDes IP licensing solutions. The United States generates the maximum revenue.